Patent · US Revoked

Fusogenic compounds for delivery of biologically active molecules

US11364200B2 · kind B2 · utility

0Cited by
0References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2018
Grant dateJun 21, 2022
Priority date
Expiry dateNov 6, 2038

Classification

  • Technology area (CPC —)General

Abstract

This invention includes fusogenic compounds, and compositions and methods of use thereof. The fusogenic compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to incorporate or encapsulate active agents, to deliver and distribute the active agents to cells, tissues, organs, and subjects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.